{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "PHARMING GRP  EO-,01", "longName": "Pharming Group N.V.", "messageBoardId": "finmb_32943", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -9.82143, "regularMarketPrice": 1.01, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1079334000000, "priceHint": 4, "epsTrailingTwelveMonths": 0.02, "epsForward": 0.09, "sharesOutstanding": 656348032, "bookValue": 0.312, "fiftyDayAverage": 1.08595, "fiftyDayAverageChange": -0.07595003, "fiftyDayAverageChangePercent": -0.06993879, "twoHundredDayAverage": 1.108355, "twoHundredDayAverageChange": -0.098355055, "twoHundredDayAverageChangePercent": -0.08873966, "marketCap": 662911488, "forwardPE": 11.222221, "priceToBook": 3.2371793, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.110000014, "regularMarketTime": 1683872766, "regularMarketDayHigh": 1.01, "regularMarketDayRange": "1.01 - 1.01", "regularMarketDayLow": 1.01, "regularMarketVolume": 3100, "regularMarketPreviousClose": 1.12, "bid": 1.064, "ask": 1.107, "bidSize": 44200, "askSize": 44200, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.01, "averageDailyVolume3Month": 818, "averageDailyVolume10Day": 310, "fiftyTwoWeekLowChange": 0.35799998, "fiftyTwoWeekLowChangePercent": 0.5490797, "fiftyTwoWeekRange": "0.652 - 1.48", "fiftyTwoWeekHighChange": -0.47000003, "fiftyTwoWeekHighChangePercent": -0.3175676, "fiftyTwoWeekLow": 0.652, "fiftyTwoWeekHigh": 1.48, "trailingAnnualDividendRate": 0.0, "trailingPE": 50.5, "trailingAnnualDividendYield": 0.0, "symbol": "PHGN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Darwinweg 24", "city": "Leiden", "zip": "2333 CR", "country": "Netherlands", "phone": "31 71 524 7400", "fax": "31 71 524 7445", "website": "https://www.pharming.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.", "fullTimeEmployees": 332, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sijmen  de Vries M.B.A., M.D., MBA", "age": 63, "title": "Pres, CEO & Exec. Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 1176000, "fmt": "1.18M", "longFmt": "1,176,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jeroen  Wakkerman", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mireille  Sanders M.Sc.", "age": 54, "title": "Chief Operations Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Susanne  Embleton", "title": "Investor Relations Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ruud  Van Outersterp", "age": 58, "title": "Chief Ethics & Compliance Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anurag  Relan M.D., MPH", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen  Toor", "age": 51, "title": "Chief Commercial Officer & GM Americas", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bruno M. L. Giannetti", "age": 70, "title": "Consultant", "yearBorn": 1952, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}